BioRestorative Therapies, Inc. Common Stock (NV) (BRTX) Stock Price

BRTXStock

$1.54−95.13%52W

Market Cap$2.13M

P/E—

PEG Ratio—

Div yield—

Beta0.83

BRTX Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-78.60%

Price vs S&P 500 (4W)-41.85%

VGM Score23.36

Book Value / Share (Quarterly)$2.38

P/TBV (Annual)1.25x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)44.18%

Cash Flow / Share (Quarterly)$-9.34

Price vs S&P 500 (YTD)-105.37%

Gross Margin (TTM)92.08%

Net Profit Margin (TTM)-3089.55%

EPS (TTM)$-15.98

10-Day Avg Trading Volume0.04M

EPS Excl Extra (TTM)$-15.98

Revenue Growth (5Y)35.07%

EPS (Annual)$-31.67

ROI (Annual)-3992.26%

Gross Margin (Annual)93.37%

Net Profit Margin (5Y Avg)-23470.44%

Cash / Share (Quarterly)$2.82

Revenue Growth QoQ (YoY)-7.32%

ROA (Last FY)-349.10%

Revenue Growth TTM (YoY)-8.47%

EBITD / Share (TTM)$-5.30

ROE (5Y Avg)-904.71%

Operating Margin (TTM)-3975.00%

Cash Flow / Share (Annual)$-24.57

P/B Ratio0.70x

P/B Ratio (Quarterly)2.29x

Net Income / Employee (Annual)$-1,095,500

EV / Revenue (TTM)-2.75x

Net Interest Coverage (TTM)-23.34x

ROA (TTM)-193.30%

EPS Incl Extra (Annual)$-31.67

Current Ratio (Annual)0.84x

Quick Ratio (Quarterly)2.23x

3-Month Avg Trading Volume0.03M

52-Week Price Return-95.13%

Revenue / Employee (TTM)$27,500

Tangible BV / Share (Quarterly)$1.97

P/S Ratio (Annual)5.91x

Asset Turnover (Annual)0.09x

52-Week High$34.40

Operating Margin (5Y Avg)-23650.23%

EPS Excl Extra (Annual)$-31.67

CapEx CAGR (5Y)21.56%

26-Week Price Return-68.70%

Quick Ratio (Annual)0.80x

13-Week Price Return-76.95%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)2.35x

Enterprise Value$-985,700

Revenue / Share Growth (5Y)31.28%

Asset Turnover (TTM)0.06x

Revenue / Employee (Annual)$27,700

Inventory Turnover (Annual)21.00x

Pretax Margin (Annual)-3959.41%

Cash / Share (Annual)$6.65

3-Month Return Std Dev85.15%

Gross Margin (5Y Avg)89.02%

Net Income / Employee (TTM)$-850,500

ROE (Last FY)-3992.26%

Net Interest Coverage (Annual)-107.00x

EPS Basic Excl Extra (Annual)$-31.67

Receivables Turnover (TTM)18.69x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-15.98

Receivables Turnover (Annual)3.53x

ROI (TTM)-423.84%

P/S Ratio (TTM)5.94x

Pretax Margin (5Y Avg)-23470.44%

Revenue / Share (Annual)$0.80

Tangible BV / Share (Annual)$22.85

Price vs S&P 500 (52W)-110.66%

Year-to-Date Return-93.45%

5-Day Price Return-12.00%

EPS Normalized (Annual)$-31.67

ROA (5Y Avg)-162.94%

Net Profit Margin (Annual)-3959.41%

Month-to-Date Return-33.91%

Cash Flow / Share (TTM)$-3.99

EBITD / Share (Annual)$-34.33

Operating Margin (Annual)-4350.05%

LT Debt / Equity (Annual)0.00x

ROI (5Y Avg)-904.24%

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$-15.98

P/TBV (Quarterly)2.76x

P/B Ratio (Annual)29.23x

Inventory Turnover (TTM)31.00x

Pretax Margin (TTM)-3089.55%

Book Value / Share (Annual)$0.80

Price vs S&P 500 (13W)-79.63%

Beta0.83x

Revenue / Share (TTM)$0.40

ROE (TTM)-423.84%

52-Week Low$1.28

gGradeD

mGradeF

vgmGradeD

BRTX Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q1 2026	May 14, 2026	-$6.00	-$2.40	+60.00%(+$3.60)
Q4 2025	Mar 26, 2026	-$7.40	-$6.40	+13.51%(+$1.00)
Q3 2025	Nov 12, 2025	-$7.60	-$6.60	+13.16%(+$1.00)
Q2 2025	Aug 12, 2025	-$8.20	-$6.00	+26.83%(+$2.20)

BRTX Analyst Recommendations

Jun 2026

Jul 2026

Aug 2026

Sep 2026

4.13

Industry Peers — Health Services(17)

Symbol	Value Score	Growth Score	Momentum Score	P/E Ratio (Annual)	Revenue Growth TTM (YoY)	Operating Margin (TTM)	ROE (TTM)	Price
BRTXBioRestorative Therapies, Inc. Common Stock (NV)	—	D	F	—	-8.5%	-3975.0%	-423.8%	$1.54
DVADaVita Inc.	B	C	B	16.0x	6.5%	15.1%	181.2%	$187.31
FMSFresenius Medical Care AG	A	D	C	10.7x	-0.5%	9.4%	7.2%	$22.17
SHCSotera Health Company Common Stock	D	B	C	65.5x	8.2%	32.6%	26.8%	$17.89
PGNYProgyny, Inc. Common Stock	C	B	C	35.2x	5.5%	8.6%	16.0%	$26.86
AGLagilon health, inc.	B	B	B	—	0.3%	-5.2%	-110.3%	$85.12
MCTACharming Medical Limited Class A Ordinary Shares	F	F	A	371.6x	—	15.4%	—	$29.36
VMDViemed Healthcare, Inc. Common Shares	B	C	C	24.2x	25.2%	7.5%	10.3%	$9.48
PARKPark Dental Partners, Inc. Common Stock	B	F	C	17.9x	—	-2.8%	-18.3%	$18.95
CCELCryo-Cell International Inc.	C	D	B	69.5x	-2.0%	0.6%	38.2%	$4.42
MGRXMangoceuticals, Inc. Common Stock	D	F	F	—	-38.9%	-4761.2%	-106.1%	$0.29
NIVFNewGenIvf Group Limited Class A ordinary shares	A	C	F	0.3x	—	390.2%	45.4%	$0.28
NIVFWNewGenIvf Group Limited Warrants	—	—	D	—	—	—	—	$0.01
OAKUOak Woods Acquisition Corporation Class A Ordinary Shares	—	F	B	174.5x	—	—	-0.6%	$0.00
OAKUROak Woods Acquisition Corporation Right	—	F	B	174.5x	—	—	-0.6%	$0.00
OAKUUOak Woods Acquisition Corporation Unit	—	F	B	174.5x	—	—	-0.6%	$0.00
OAKUWOak Woods Acquisition Corporation Warrant	—	—	F	—	—	—	—	$0.00
QIPTQuipt Home Medical Corp. Ordinary Shares	B	B	B	—	9.5%	-1.2%	-10.5%	$0.00

About BioRestorative Therapies, Inc. Common Stock (NV)

BioRestorative Therapies is a biotechnology company developing cell-based regenerative medicine therapies using adult stem cells. The company is advancing BRTX-100, an autologous mesenchymal stem cell therapy for disc and spine disorders, and a brown adipose-derived cell therapy program targeting obesity and metabolic diseases.